Diprifusor - Target Controlled Infusion (TCI) of Diprivan
Overview: Diprifusor is the first commercially available TCI system and has been developed to enhance the control of IV anaesthesia with Diprivan (propofol). The anaesthesia slides below provide detailed information regarding: Diprivan's pharmacokinetic properties, Clinical benefits of Diprivan, Target Controlled Infusion (TCI) benefits and systems, Diprifusor TCI clinical studies.
Number of Slides: 70
Date added: 2002-11-12
DownloadPage tools
Contact
Information for
This is an AstraZeneca International website for healthcare professionals and is not intended for the following audiences who should use the links below:
